You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
歐盟反壟斷監管機構無法信服Illumina對Grail出價的補救措施
格隆匯 03-04 17:55
格隆匯3月4日丨據路透引述知情人士透露,美國生命科學公司Illumina(ILMN.US)提出降價並允許競爭對手繼續使用其技術,但這一提議尚未説服正在審查其以80億美元現金加股票收購Grail的歐盟反壟斷監管機構。這樣的懷疑可能意味着,如果Illumina想要獲得歐盟批准收購這家癌症檢測試劑生產商,它可能需要增加其擬議的補救措施。Illumina去年8月完成了對這家癌症檢測試劑生產商的收購,但在獲得監管機構批准前仍保持獨立公司的身份。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account